GADICKE ANSBERT enters AKTIS ONCOLOGY, INC. with 341.71K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Indirect Derivatives
Filed: 1/8/2026ACC: 0001231919-26-000025
341.71K
Baseline shares
0.00
Direct ownership
0 positions
8.81M
Derivative underlying
3 instruments
1
Security positions
341.71K indirect
Non-Derivative Holdings1
Common Stock
IndirectShares owned341.71K
Total
341.71K indirect341.71K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 341.71K | Indirect |
| Total | 341.71K | 341.71K indirect |
Derivative Holdings3
Series Seed Redeemable Convertible Preferred Stock
IndirectUnderlying security
Common Stock
Underlying shares
1.31M
Shares owned
N/A
Exercise price
0
Expiration
—
Exercise window
—
Series A Redeemable Convertible Preferred Stock
IndirectUnderlying security
Common Stock
Underlying shares
5.91M
Shares owned
N/A
Exercise price
0
Expiration
—
Exercise window
—
Series B Redeemable Convertible Preferred Stock
IndirectUnderlying security
Common Stock
Underlying shares
1.58M
Shares owned
N/A
Exercise price
0
Expiration
—
Exercise window
—
Total
Underlying
8.81M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Series Seed Redeemable Convertible Preferred Stock Indirect | Common Stock | 0 | — | — | 1.31M | N/A |
| Series A Redeemable Convertible Preferred Stock Indirect | Common Stock | 0 | — | — | 5.91M | N/A |
| Series B Redeemable Convertible Preferred Stock Indirect | Common Stock | 0 | — | — | 1.58M | N/A |
| Total | 8.81M | 0.00 | ||||